Correlation of tumor necrosis factor α (TNFα) with high Caspase 3-like activity in myelodysplastic syndromes

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 201-207

  Mundle, Suneel D ^a   Reza, Samina ^a   Ali, Ambereen ^a   Mativi, B Yifwayimare ^a   Shetty, Vilasini ^a   Venugopal, Parmeswaran ^a   Gregory, Stephanie A ^a   Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Caspase 1; Caspase 3; HL60 cells; Inhibition; Myelodysplastic syndromes (MDS); Pentoxifylline; Tumor necrosis factor (TNF )

Indexed keywords

CASPASE; CASPASE 3; CASPASE INHIBITOR; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; PENTOXIFYLLINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL STRAIN HL 60; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ANTAGONISM; FLUOROMETRY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIGNAL TRANSDUCTION;

APOPTOSIS; BONE MARROW CELLS; CASPASE 1; CASPASE 3; CASPASES; CELL SEPARATION; CELLS, CULTURED; HL-60 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MYELODYSPLASTIC SYNDROMES; PENTOXIFYLLINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032972264     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00072-5     Document Type: Article

References (20)

1. Binet J.L., Mentz F., Merle-Beral H. Apoptosis in blood diseases. Hematol. Cell. Ther. 38:1996;253-264.
2. Yoshida Y. Apoptosis as a parameter of cytokine treatment in myelodysplasia. Leuk. Res. 21:1997;427-428.
3. Mundle S., Venugopal P., Cartlidge J., Pandav D., Broady-Robinson L., Gezer S., Robin E., Rifkin S., Klein M., Alston D., Hernandez B., Rosi D., Alvi S., Shetty V., Gregory S.A., Raza A. Indication of an involvement of interleukin-1β converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 88:1996;2640-2647.
4. Shetty V., Mundle S., Alvi S., Showel M., Broady-Robinson L., Dar S., Borok R., Showel J., Gregory S., Rifkin S., Gezer S., Parcharidou A., Venugopal P., Shah R., Hernandez B., Klein M., Alston D., Robin E., Dominguez C., Raza A. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk. Res. 20:1996;891-900.
5. Gersuk G.M., Beckham C., Loken M.R., Kiener P., Anderson J.E., Ferrand A., Troutt A.B., Ledbetter J.A., Deeg H.J. A role for tumor necrosis factor-α, fas and fas-ligand in marrow failure associated with myelodysplastic syndrome. Br. J. Haematol. 103:1998;176-188.
6. Wyllie A.H. Apoptosis: an overview. Br. Med. Bull. 53:1997;451-465.
7. Enari M., Talanian R.V., Wong W.W., Nagta S. Sequential activation of ICE-like and CPP-32-like proteases during fas-mediated apoptosis. Nature. 380:1996;723-726.
8. Mundle S.D., Gregory S.A., Preisler H.D., Raza A. Enzymatic programming of apoptotic cell death. Pathobiology. 64:1996;161-170.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-252.
10. Ali A., Mundle S., Ragasa D., Reza S., Shetty V., Mativi B.Y., Cartlidge J., Azharuddin M., Raza A. Sequential activation of caspases during spontaneous apoptosis of bone marrow cells in myelodysplasia. Blood. 90(suppl. 1):1997;521a.
11. Parker J.E., Mufti G.J. Ineffective hematopoiesis and apoptosis in myelodysplastic syndromes. Br. J. Hematol. 101:1998;220-230.
12. Raza A., Gezer S., Mundle S., Borok R., Rifkin S., Iftikhar A., Shetty V., Parcharidou A., Loew J., Alvi S., Chaney C., Showel J., Gregory S., Preisler H. Apoptosis in bone marrow biopsies involving stromal and hematopoietic cells in 45 patients with myelodysplastic syndromes. Blood. 86:1995;268-276.
13. Rajapaksa R., Ginzton N., Rott L.S., Greenberg P.L. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood. 88:1996;4275-4287.
14. Hellstrom-Lindberg E., Kanter-Lewensohn L., Ost A. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk. Res. 21:1997;415-425.
15. Parker J.E., Fishlock K.L., Mijovic A., Pagliuca A., Mufti G.J. Leukemic progression in myelodysplastic syndromes (MDS) is associated with decreased apoptosis and a reduced ration of pro- versus anti-apoptotic Bcl-2 related proteins. Blood. 90:1997;520a.
16. Lepelley P., Campergue L., Grardel N., Preudhomme C., Cosson A., Fenaux P. Is apoptosis a massive process in myelodysplastic syndromes? Br. J. Hematol. 95:1996;368-371.
17. Bokhari S.A.J., Abbas A., Yousuf N., Mehdi A., Umerani A., Qadir K., Sheikh Y., Akhtar S., Chugtai S., Preisler H., Raza A. Cell cycle parameters as biological predictors of prognosis in AML: a review and update of cell cycle kinetics and remission induction/duration in acute leukemia. Leuk. Lymphoma. 6:1992;197-207.
18. Horikawa K., Nakakuma H., Kawaguchi T., Iwamoto N., Nagakura S., Kagimoto T., Takatsuki K. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes. Blood. 90:1997;2716-2722.
19. Dezube B.J., Sherman M.L., Fridovich-Keil J.L., Allen-Ryan J., Pardee A.B. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol. Immunother. 36:1993;57-60.
20. Raza A., Venugopal P., Gezer S., Gregory S., Dong L.-M., Leurgens S., Mundle S., Shetty V., Alvi S., Ali A., Span L., Dar S., Hines C., Hsu W.-T., Loew J., Borok R., Hernandez B., Robin E., Shelby R., Alston D., Shah R., Preisler H. Pilot study of pentoxifylline and ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes. Hiddemann W., Buchner T., Wormann B., Ritter J., Creutzig U., Keating M., Plunkett W. Hematology and Blood Transfusionvol. 39, Acute Leukemias VII - Experimental Approaches and Novel Therapies. 1998;Springer, Berlin, Heidelberg. pp. 42-51.